Nuvation Bio (NYSE: NUVB) is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.

Pharmaceutical

Nuvation Bio

David Hung

Colleen Sjogren

Evelyn Shu

Susan Baum

Robert Devita

Stephen Dang

Liang Fang

Kerry Wentworth

David Liu

Stacy Markel

David Hanley

Gary Hattersley

Directors and Senior Directors

Medical and Clinical Team

Leadership Team

Operations Team

Finance and Accounting

Teams at Nuvation Bio

Directors and Senior Directors

Medical and Clinical Team

Leadership Team

Operations Team

Finance and Accounting